IQAIF (Imaging Biometrics) Beginning Cash Position: $0.10 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Imaging Biometrics Beginning Cash Position?

Imaging Biometrics IQAIF Beginning Cash Position is $0.10 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Imaging Biometrics's Beginning Cash Position for the quarter that ended in Dec. 2025 was $0.10 Mil.

Imaging Biometrics's quarterly Beginning Cash Position declined from Dec. 2024 ($0.24 Mil) to Jun. 2025 ($0.07 Mil) but then increased from Jun. 2025 ($0.07 Mil) to Dec. 2025 ($0.10 Mil).

Imaging Biometrics's annual Beginning Cash Position declined from Dec. 2023 ($0.40 Mil) to Dec. 2024 ($0.18 Mil) and declined from Dec. 2024 ($0.18 Mil) to Dec. 2025 ($0.07 Mil).

Imaging Biometrics Beginning Cash Position Related Terms

Imaging Biometrics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Imaging Biometrics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imaging Biometrics Beginning Cash Position Chart

Imaging Biometrics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.89 0.40 0.18 0.07

Imaging Biometrics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.18 0.24 0.07 0.10

Imaging Biometrics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.10 Mil mean?
Imaging Biometrics (IQAIF) has a Beginning Cash Position of $0.10 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Imaging Biometrics and its competitors.
Is Imaging Biometrics' Beginning Cash Position too high?
Imaging Biometrics' current Beginning Cash Position is $0.10 Mil.
How does Imaging Biometrics' Beginning Cash Position compare to VEEV and BTSG?
Imaging Biometrics' Beginning Cash Position of $0.10 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Imaging Biometrics and its competitors. Imaging Biometrics's current Beginning Cash Position is $0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current Beginning Cash Position of $0.10 Mil. The current Beginning Cash Position is $0.10 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current Beginning Cash Position is $0.10 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imaging Biometrics Business Description

Other Exchanges IBAI:UK
Address IFC 5, Channel Islands, Saint Helier, JEY, JE1 1ST
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.